PetMeds is a direct-to-consumer online pet pharmacy and health retailer that operates the PetMeds and PetCareRx brands. The company sells prescription medications, over-the-counter treatments, supplements, and pet food for dogs, cats, and horses. PetMeds serves as an alternative to brick-and-mortar veterinary clinics by managing the prescription verification process and shipping medications directly to consumers. The business model relies on the AutoShip subscription program, which automates recurring refills for chronic and preventative treatments. This program generates the majority of company sales and drives customer retention. PetMeds generates profit by selling products at a margin, with private label items providing higher profitability than branded drugs. Through the acquisition of PetCareRx, the company expanded its catalog to include premium food and treats. Current growth strategies focus on developing a B2B pharmacy-as-a-service model by licensing its regulated pharmacy and fulfillment infrastructure to partners such as veterinary clinics and employers. PetMeds is also modernizing its technology platforms and launching a loyalty program to improve customer lifetime value. The company operates licensed pharmacies across all 50 states and utilizes a staff of trained specialists to process orders through its digital platforms and contact centers.
Read full business overview →Mid to long-term bullish thesis
View →Mid to long-term bearish thesis
View →Mid to long-term bull-bear debate
View → NEWSummary and scoring of the bull-bear debate
View →Find ideas with similar bull or bear theses
View →Investor-relevant company attributes
View →Key risks to the business
View →Comparisons of annual risk disclosures
View →